Núcleo de Pós-Graduação e Pesquisa-Santa Casa de Belo Horizonte, Av. Francisco Sales 1111, Belo Horizonte, MG, Brazil.
Clin Chim Acta. 2010 Oct 9;411(19-20):1457-60. doi: 10.1016/j.cca.2010.05.039. Epub 2010 Jun 4.
Recent studies have suggested that impaired nitric oxide (NO) formation in preeclampsia may result from increased concentrations of an endogenous NO synthase inhibitor, the asymmetric dimethylarginine (ADMA). However, no previous study has examined whether a negative association exists between ADMA and nitrite concentrations in preeclampsia. Moreover, no previous study has compared ADMA and nitrite levels in black and white preeclamptic pregnant women.
We measured plasma nitrite concentrations using an ozone-based chemiluminescence assay, and plasma ADMA levels using enzyme immunoassays in 94 pregnant (47 healthy pregnant: 16 blacks and 31 whites; and 47 preeclamptic: 14 blacks and 33 whites).
We found higher ADMA (2.199 + or -0.016 micromol/l vs. 2.112 + or - 0.012 micromol/l; P<0.0001) and lower plasma nitrite levels (102 + or - 7.1 nmol/l vs. 214.8 + or - 26.1 nmol/l; P<0.0001) in preeclamptic compared with healthy pregnant women. Black pregnant had higher ADMA levels than white pregnant women (P<0.05), both in preeclamptic (2.239 + or - 0.020 micromol/l vs. 2.144 + or - 0.019 micromol/l) and in healthy pregnant (2.172 + or - 0.025 micromol/l vs. 2.077 + or - 0.018 micromol/l). Conversely, we found no significant effects of ethnicity on the plasma nitrite levels, both in healthy pregnant and in preeclamptic women (P>0.05). We found a significant negative correlation (P<0.05) between these markers (r=-0.28; P<0.05).
Our findings show higher ADMA and lower nitrite levels in preeclamptic compared with healthy pregnant, and the concentrations of these biomarkers are inversely associated. While ethnicity affected ADMA concentrations, no such effect was found with respect to nitrite levels. These results may have important implications for studies on NO biology and therapeutic approaches of preeclampsia.
最近的研究表明,子痫前期中一氧化氮(NO)形成受损可能是由于内源性 NO 合酶抑制剂不对称二甲基精氨酸(ADMA)浓度增加所致。然而,以前的研究尚未检查 ADMA 与子痫前期中硝酸盐浓度之间是否存在负相关关系。此外,以前的研究也没有比较过黑人和白人子痫前期患者的 ADMA 和硝酸盐水平。
我们使用基于臭氧的化学发光测定法测量了血浆硝酸盐浓度,并使用酶免疫测定法测量了血浆 ADMA 水平,共纳入 94 名孕妇(47 名健康孕妇:16 名黑人,31 名白人;47 名子痫前期孕妇:14 名黑人,33 名白人)。
我们发现子痫前期孕妇的 ADMA(2.199 ± 0.016 μmol/L 比 2.112 ± 0.012 μmol/L;P<0.0001)和血浆硝酸盐水平(102 ± 7.1 nmol/L 比 214.8 ± 26.1 nmol/L;P<0.0001)均高于健康孕妇。黑人孕妇的 ADMA 水平高于白人孕妇(P<0.05),无论是子痫前期(2.239 ± 0.020 μmol/L 比 2.144 ± 0.019 μmol/L)还是健康孕妇(2.172 ± 0.025 μmol/L 比 2.077 ± 0.018 μmol/L)。相反,我们发现种族对健康孕妇和子痫前期孕妇的血浆硝酸盐水平均无显著影响(P>0.05)。我们发现这些标志物之间存在显著的负相关关系(P<0.05)(r=-0.28;P<0.05)。
我们的研究结果表明,子痫前期孕妇的 ADMA 水平较高,硝酸盐水平较低,并且这些生物标志物的浓度呈负相关。虽然种族会影响 ADMA 浓度,但对硝酸盐水平没有这种影响。这些结果可能对 NO 生物学和子痫前期治疗方法的研究具有重要意义。